Debra Brennan

Company: Nimbus Therapeutics

Job title: Senior Director, Protein Sciences & Structural Biology

Seminars:

Roundtable Discussion: Tackling Industry-Wide Challenges with Hard-to-Drug Targets for Future Hit ID Strategies 11:15 am

Understanding how new target classes would require rethinking both screening methods and library composition Formulating a strategy to inform how disease context influences hit finding opportunities Questioning how to prioritize different target classes based on stability and mechanism of actionRead more

day: Day Two